Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations

References

• Cowan LD. The epidemiology of the epilepsies in children. Ment. Retard. Dev. Disabil. Res. Rev.8(3), 171–181 (2002).
   PubMedGoogle Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry164(6), 942–948 (2007).
   PubMed Web of Science ®Google Scholar
• Rappley MD. Clinical practice. Attention deficit-hyperactivity disorder. N. Engl. J. Med.352(2), 165–173 (2005).
   PubMed Web of Science ®Google Scholar
• Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens. Statement16, 1–37 (1998).
   PubMedGoogle Scholar
• Parisi P, Moavero R, Verrotti A, Curatolo P. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev. (2009) (Epub ahead of print).
   Google Scholar
• Dunn DW, Austin JK, Huster GA. Behaviour problems in children with new-onset epilepsy. Seizure6(4), 283–287 (1997).
   PubMedGoogle Scholar
• Kanner AM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin. Neurol.28(3), 379–388 (2008).
   PubMedGoogle Scholar
• Kirov R, Kinkelbur J, Banaschewski T, Rothenberger A. Sleep patterns in children with attention-deficit/hyperactivity disorder, tic disorder, and comorbidity. J. Child Psychol. Psychiatry48(6), 561–570 (2007).
   PubMedGoogle Scholar
• Hesdorffer DC, Ludvigsson P, Olafsson E, Gudmundsson G, Kjartansson O, Hauser WA. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch. Gen. Psychiatry61(7), 731–736 (2004).
   PubMed Web of Science ®Google Scholar
• Richer LP, Shevell MI, Rosenblatt BR. Epileptiform abnormalities in children with attention-deficit-hyperactivity disorder. Pediatr. Neurol.26(2), 125–129 (2002).
   PubMedGoogle Scholar
• Hughes JR, DeLeo AJ, Melyn MA. The electroencephalogram in attention deficit-hyperactivity disorder: emphasis on epileptiform discharges. Epilepsy Behav.1(4), 271–277 (2000).
   PubMed Web of Science ®Google Scholar
• Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics105(5), 1158–1170 (2000).
   PubMed Web of Science ®Google Scholar
• Davies S, Heyman I, Goodman R. A population survey of mental health problems in children with epilepsy. Dev. Med. Child Neurol.45(5), 292–295 (2003).
   PubMed Web of Science ®Google Scholar
• Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood. Dev. Med. Child Neurol.45(1), 50–54 (2003).
   PubMed Web of Science ®Google Scholar
• Thome-Souza S, Kuczynski E, Assumpcao F Jr et al. Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy? Epilepsy Behav.5(6), 988–994 (2004).
   PubMed Web of Science ®Google Scholar
• Hermann B, Jones J, Dabbs K et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain130(Pt 12), 3135–3148 (2007).
   PubMed Web of Science ®Google Scholar
• Sherman EM, Slick DJ, Connolly MB, Eyrl KL. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia48(6), 1083–1091 (2007).
   PubMed Web of Science ®Google Scholar
• Barkley RA. Attention-Deficit/Hyperactivity Disorder, Third Edition: A Handbook for Diagnosis and Treatment. Guilford, New York, USA (2006).
   Google Scholar
• Burd L, Kerbeshian J, Fisher W. Does the use of phenobarbital as an anticonvulsant permanently exacerbate hyperactivity? Can. J. Psychiatry32(1), 10–13 (1987).
   PubMedGoogle Scholar
• Domizio S, Verrotti A, Ramenghi LA, Sabatino G, Morgese G. Anti-epileptic therapy and behaviour disturbances in children. Childs Nerv. Syst.9(5), 272–274 (1993).
   PubMedGoogle Scholar
• Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology62(6), 872–877 (2004).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Huh K, Gallagher BB, King DW. Comparative cognitive effects of anticonvulsants. Neurology40(3 Pt 1), 391–394 (1990).
   PubMed Web of Science ®Google Scholar
• Riva D, Devoti M. Discontinuation of phenobarbital in children: effects on neurocognitive behavior. Pediatr. Neurol.14(1), 36–40 (1996).
   PubMedGoogle Scholar
• Besag FM. Behavioural effects of the new anticonvulsants. Drug Saf.24(7), 513–536 (2001).
   PubMed Web of Science ®Google Scholar
• Holmes GL. Gabapentin for treatment of epilepsy in children. Semin. Pediatr. Neurol.4(3), 244–250 (1997).
   PubMedGoogle Scholar
• Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ, Mikati MA. Behavioral side effects of gabapentin in children. Epilepsia37(1), 87–90 (1996).
   PubMed Web of Science ®Google Scholar
• Mikati MA, Choueri R, Khurana DS, Riviello J, Helmers S, Holmes G. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability. J. Intellect. Disabil. Res.42(Suppl. 1), 57–62 (1998).
   PubMed Web of Science ®Google Scholar
• Aldenkamp AP, Baker G, Mulder OG et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia41(9), 1167–1178 (2000).
   PubMed Web of Science ®Google Scholar
• Bourgeois BF. Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia39(9), 913–921 (1998).
   PubMed Web of Science ®Google Scholar
• Burton LA, Harden C. Effect of topiramate on attention. Epilepsy Res.27(1), 29–32 (1997).
   PubMed Web of Science ®Google Scholar
• Martin R, Kuzniecky R, Ho S et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology52(2), 321–327 (1999).
   PubMed Web of Science ®Google Scholar
• Aman MG, Werry JS, Paxton JW, Turbott SH, Stewart AW. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia31(1), 51–60 (1990).
   PubMedGoogle Scholar
• Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics107(1), 115–122 (2001).
   PubMed Web of Science ®Google Scholar
• Johnson M, Ostlund S, Fransson G, Kadesjo B, Gillberg C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J. Atten. Disord.12(5), 394–401 (2009).
   PubMed Web of Science ®Google Scholar
• Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int. Rev. Psychiatry18(2), 155–172 (2006).
   PubMed Web of Science ®Google Scholar
• Milte CM, Sinn N, Howe PR. Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer’s disease: towards an omega-3 index for mental health? Nutr. Rev.67(10), 573–590 (2009).
   PubMed Web of Science ®Google Scholar
• Gaby AR. Natural approaches to epilepsy. Altern. Med. Rev.12(1), 9–24 (2007).
   PubMedGoogle Scholar
• Kossoff EH. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol.3(7), 415–420 (2004).
   PubMed Web of Science ®Google Scholar
• Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids. Epilepsia37(Suppl. 1), S81–S95 (1996).
   PubMed Web of Science ®Google Scholar
• Aldenkamp A, Arends J. The relative influence of epileptic EEG discharges, short nonconvulsive seizures, and type of epilepsy on cognitive function. Epilepsia45(1), 54–63 (2004).
   PubMed Web of Science ®Google Scholar
• Aldenkamp AP, Arends J, Overweg-Plandsoen TC et al. Acute cognitive effects of nonconvulsive difficult-to-detect epileptic seizures and epileptiform electroencephalographic discharges. J. Child Neurol.16(2), 119–123 (2001).
   PubMedGoogle Scholar
• Holtmann M, Becker K, Kentner-Figura B, Schmidt MH. Increased frequency of rolandic spikes in ADHD children. Epilepsia44(9), 1241–1244 (2003).
   PubMed Web of Science ®Google Scholar
• Marston D, Besag F, Binnie CD, Fowler M. Effects of transitory cognitive impairment on psychosocial functioning of children with epilepsy: a therapeutic trial. Dev. Med. Child Neurol.35(7), 574–581 (1993).
   PubMedGoogle Scholar
• Perrine K, Kiolbasa T. Cognitive deficits in epilepsy and contribution to psychopathology. Neurology53(5 Suppl. 2), S39–S48 (1999).
   PubMed Web of Science ®Google Scholar
• Anderson GM, Dover MA, Yang BP et al. Adrenomedullary function during cognitive testing in attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry39(5), 635–643 (2000).
   PubMed Web of Science ®Google Scholar
• Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia32(2), 168–173 (1991).
   PubMedGoogle Scholar
• Weinshenker D, Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol. Ther.94(3), 213–233 (2002).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Heydrich J, Dodds A, Whitney J et al. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav.10(3), 384–388, (2007).
   PubMedGoogle Scholar
• Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry57(11), 1273–1284 (2005).
   PubMed Web of Science ®Google Scholar
• Rubia K, Smith AB, Brammer MJ, Toone B, Taylor E. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am. J. Psychiatry162(6), 1067–1075 (2005).
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol. Psychiatry57(11), 1263–1272 (2005).
   PubMed Web of Science ®Google Scholar
• Zang YF, Jin Z, Weng XC et al. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality. Brain Dev.27(8), 544–550 (2005).
   PubMed Web of Science ®Google Scholar
• Meeren H, van Luijtelaar G, Lopes da Silva F, Coenen A. Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory. Arch. Neurol.62, 371–376 (2005).
   PubMedGoogle Scholar
• Kapucu LO, Serdaroglu A, Okuyaz C, Kose G, Gucuyener K. Brain single photon emission computed tomographic evaluation of patients with childhood absence epilepsy. J. Child Neurol.18(8), 542–548 (2003).
   PubMed Web of Science ®Google Scholar
• Auclair L, Jambaque I, Dulac O, LaBerge D, Sieroff E. Deficit of preparatory attention in children with frontal lobe epilepsy. Neuropsychologia43(12), 1701–1712 (2005).
   PubMed Web of Science ®Google Scholar
• McDonald CR, Delis DC, Norman MA, Wetter SR, Tecoma ES, Iragui VJ. Response inhibition and set shifting in patients with frontal lobe epilepsy or temporal lobe epilepsy. Epilepsy Behav.7(3), 438–446 (2005).
   PubMed Web of Science ®Google Scholar
• Riva D, Avanzini G, Franceschetti S et al. Unilateral frontal lobe epilepsy affects executive functions in children. Neurol. Sci.26(4), 263–270 (2005).
   PubMed Web of Science ®Google Scholar
• Blumenfeld H, Rivera M, McNally KA, Davis K, Spencer DD, Spencer SS. Ictal neocortical slowing in temporal lobe epilepsy. Neurology63(6), 1015–1021 (2004).
   PubMedGoogle Scholar
• Franceschi M, Bressi S, Minicucci F et al. Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry59(4), 427–431 (1995).
   PubMedGoogle Scholar
• McIntyre DC, Gilby KL. Genetically seizure-prone or seizure-resistant phenotypes and their associated behavioral comorbidities. Epilepsia48(Suppl. 9), 30–32 (2007).
   PubMedGoogle Scholar
• Gilby KL. A new rat model for vulnerability to epilepsy and autism spectrum disorders. Epilepsia49(Suppl. 8), 108–110 (2008).
   PubMedGoogle Scholar
• Gonzalez-Heydrich J, Luna L, Rao S et al. Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Presented at: American Academy of Child and Adolescent Psychiatry Anuual Meeting. Honolulu, Hawaii, 27 October–1 November 2009.
   Google Scholar
• The MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry56(12), 1088–1096 (1999).
   PubMed Web of Science ®Google Scholar
• Torres AR, Whitney J, Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav.12(2), 217–233 (2008).
   PubMed Web of Science ®Google Scholar
• Gould MS, Walsh BT, Munfakh JL et al. Sudden death and use of stimulant medications in youths. Am. J. Psychiatry166(9), 992–1001 (2009).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Heydrich J, Weiss M, Connolly M et al. Pharmacological management of a youth with ADHD and a seizure disorder. J. Am. Acad. Child Adolesc. Psychiatry45(12), 1527–1532 (2006).
   PubMedGoogle Scholar
• Tan M, Appleton R. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy. Arch. Dis. Child.90(1), 57–59 (2005).
   PubMed Web of Science ®Google Scholar
• Feldman H, Crumrine P, Handen BL, Alvin R, Teodori J. Methylphenidate in children with seizures and attention-deficit disorder. Am. J. Dis. Child.143(9), 1081–1086 (1989).
   PubMedGoogle Scholar
• Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J. Pediatrics130(4), 670–674 (1997).
   PubMed Web of Science ®Google Scholar
• Semrud-Clikeman M, Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia40(2), 211–215 (1999).
   PubMed Web of Science ®Google Scholar
• Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin. Investig. Drugs17(1), 77–84 (2008).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Heydrich J, Pandina GJ, Fleisher CA et al. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series. J. Child Adolesc. Psychopharmacol.14(2), 295–310 (2004).
   PubMed Web of Science ®Google Scholar
• Ounsted C. The hyperkinetic syndrome in epileptic children. Lancet269(6885), 303–311 (1955).
   PubMedGoogle Scholar
• Gonzalez-Heydrich J, Hsin O, Hickory M, et al. Comparisons of response to stimulant preperations in pediatric epilepsy Presented at: American Academy of Child and Adolescent Psychiatry Annual Meeting. Washington, DC, USA 19–24 October 2004.
   Google Scholar
• Appleby JG. Use of dextroamphetamine in epilepsy. J. S. C. Med. Assoc.81(5), 281–282 (1985).
   PubMedGoogle Scholar
• Livingston S, Pauli LL. Dextroamphetamine for epilepsy. JAMA233(3), 278–279 (1975).
   PubMedGoogle Scholar
• Dunn DW, Kronenberger WG. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin. Pediatr. Neurol.12(4), 222–228 (2005).
   PubMedGoogle Scholar
• Michelson D, Allen AJ, Busner J et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am. J. Psychiatry159(11), 1896–1901 (2002).
   PubMed Web of Science ®Google Scholar
• Wernicke JF, Holdridge KC, Jin L et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev. Med. Child Neurol.49(7), 498–502 (2007).
   PubMedGoogle Scholar
• Kashani J, Ruha AM. Isolated atomoxetine overdose resulting in seizure. J. Emerg. Med.32(2), 175–178 (2007).
   PubMed Web of Science ®Google Scholar
• Hernandez A, Barragan P. Efficacy of atomoxetine treatment in children with ADHD and epilepsy. Presented at: Annual Meeting of the International League Against Epilepsy. Paris, France, 28 August–1 September 2005.
   Google Scholar
• Settle EC Jr. Bupropion sustained release: side effect profile. J. Clin. Psychiatry59(Suppl. 4), 32–36 (1998).
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Clin. Pharmacokinet.40(10), 753–772 (2001).
   PubMed Web of Science ®Google Scholar
• Behar D, Schaller J, Spreat S. Extreme reduction of methylphenidate levels by carbamazepine. J. Am. Acad. Child Adolesc. Psychiatry37(11), 1128–1129 (1998).
   PubMed Web of Science ®Google Scholar
• Schaller JL, Behar D. Carbamazepine and methylphenidate in ADHD. J. Am. Acad. Child Adolesc. Psychiatry38(2), 112–113 (1999).
   PubMed Web of Science ®Google Scholar
• Gross-Tsur V. Carbamazepine and methylphenidate. J. Am. Acad. Child Adolesc. Psychiatry38(6), 637 (1999).
   PubMedGoogle Scholar
• Kanner AM, Gidal BE. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs. Int. Rev. Neurobiol.83, 397–416 (2008).
   PubMedGoogle Scholar
• Garrettson LK, Perel JM, Dayton PG. Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. JAMA207(11), 2053–2056 (1969).
   PubMed Web of Science ®Google Scholar
• Ghofrani M. Possible phenytoin–methylphenidate interaction. Dev. Med. Child Neurol.30(2), 267–268 (1988).
   PubMed Web of Science ®Google Scholar
• Kupferberg HJ, Jeffery W, Hunninghake DB. Effect of methylphenidate on plasma anticonvulsant levels. Clin. Pharmacol. Ther.13(2), 201–204 (1972).
   PubMedGoogle Scholar
• Mirkin BL, Wright F. Drug interactions: effect of methylphenidate on the disposition of diphenylhydantoin in man. Neurology21(11), 1123–1128 (1971).
   PubMed Web of Science ®Google Scholar
• Frey HH, Kampmann E. Interaction of amphetamine with anticonvulsant drugs. II. Effect of amphetamine on the absorption of anticonvulsant drugs. Acta Pharmacol. Toxicol. (Copenh.)24(4), 310–316 (1966).
   PubMedGoogle Scholar